2022
DOI: 10.1371/journal.pone.0270819
|View full text |Cite
|
Sign up to set email alerts
|

Drug-susceptible tuberculosis treatment outcomes and its associated factors among inmates in prison settings in Bauchi State, Nigeria, 2014–2018

Abstract: Tuberculosis (TB) is a contagious disease and its transmissibility is increased in congregate settings. TB incidence rates are five-to-fifty times higher among inmates in prison settings than the general population which has a direct impact on the outcome of TB treatment. There is paucity of information on TB treatment outcomes and its associated factors in Nigerian prison settings. We therefore assessed TB treatment outcomes among inmates in prison settings in Bauchi State, Nigeria. We conducted a retrospecti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Treatment success rate (TSR) is a helpful measure for evaluating the efficacy of the tuberculosis control campaign. The implication of a low TSR is that TB-infected patients may not be receiving adequate treatment and stand the risk of developing drug-resistant TB which could serve as a potential reservoir for the transmission of MDR-TB [ 25 ]. Although the overall treatment success rate of 65.8% obtained in this study was lower compared to the 86% global average achieved in 2020 [ 26 ] and the 90% target advocated by WHO, this was higher than that of 57.4% in Kwazulu-Natal Province [ 1 ] but lower than that of 80% from Gauteng Province in South Africa [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…Treatment success rate (TSR) is a helpful measure for evaluating the efficacy of the tuberculosis control campaign. The implication of a low TSR is that TB-infected patients may not be receiving adequate treatment and stand the risk of developing drug-resistant TB which could serve as a potential reservoir for the transmission of MDR-TB [ 25 ]. Although the overall treatment success rate of 65.8% obtained in this study was lower compared to the 86% global average achieved in 2020 [ 26 ] and the 90% target advocated by WHO, this was higher than that of 57.4% in Kwazulu-Natal Province [ 1 ] but lower than that of 80% from Gauteng Province in South Africa [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…It occurs when the Mycobacterium strain becomes resistant to both Isoniazid (INH) and Rifampicin (RIF), the two powerful anti-TB drugs [4,5]. The management and treatment of MDR-TB are complex, and it is hard to achieve favourable treatment outcomes as compared to drug-sensitive TB, even under optimal circumstances [6][7][8]. The treatment is usually prolonged with a minimum duration of 24 months [9].…”
Section: Introductionmentioning
confidence: 99%